CVR: 39055988
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017 and dissolved in 2024. The company was registered under the industry Reklamebureauer. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity amounted to DKK 1,644,740.
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 1.858 companies in Reklamebureauer
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of December 19, 2024, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has stepped down as auditor of EUSA Pharma (Denmark) ApS.
As of December 19, 2024, Nicolai Jung has stepped down as liquidator of EUSA Pharma (Denmark) ApS.
On December 19, 2024, EUSA Pharma (Denmark) ApS exited liquidation.
EUSA Pharma (Denmark) ApS was dissolved on December 19, 2024.
As of June 3, 2024, Nicolai Jung is registered as liquidator of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Luigi Longinotti has stepped down as director of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Joakim Karl Viktor Åberg has stepped down as director of EUSA Pharma (Denmark) ApS.
As of June 3, 2024, Francesco Palombi has stepped down as director of EUSA Pharma (Denmark) ApS.
On June 3, 2024, EUSA Pharma (Denmark) ApS entered liquidation.
EUSA Pharma (Denmark) ApS has published its annual report for 2023. Gross profit came to DKK 1,928,889, and the net result was DKK 141,012.
EUSA Pharma (Denmark) ApS has published its annual report for 2022. Gross profit came to DKK 3,037,780, and the net result was DKK 198,473.
As of October 13, 2022, Joakim Karl Viktor Åberg is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Francesco Palombi is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Emma Jane Johnson has stepped down as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Dev Kumar has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2021. Gross profit came to DKK 9,429,497, and the net result was DKK 482,679.
As of March 16, 2022, Luigi Longinotti is registered as director of EUSA Pharma (Denmark) ApS.
As of March 16, 2022, Frank Carsten Thiel has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2020. Gross profit came to DKK 9,829,410, and the net result was DKK 607,118.
As of May 25, 2021, Frank Carsten Thiel is registered as director of EUSA Pharma (Denmark) ApS.
As of May 25, 2021, Lee Scot Morley has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2019. Gross profit came to DKK 2,058,784, and the net result was DKK 228,408.
EUSA Pharma (Denmark) ApS has published its interim report for the period November 2, 2017 – December 31, 2018.
As of November 2, 2017, CROWE STATSAUTORISERET REVISIONSINTERESSENTSKAB has been appointed auditor of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Lee Scot Morley is registered as director of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Emma Jane Johnson is registered as director of EUSA Pharma (Denmark) ApS.
As of November 2, 2017, Dev Kumar is registered as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS was founded on November 2, 2017.
Companies in the same industry and area
CVR 29000255
CVR 46604563
CVR 44208474
CVR 27357474
CVR 21489379
companydata.dk